Host: Paul Raeburn
Guest: Charles Bennett, MD
The FDA is supposed to monitor adverse drug reactions after drugs are approved and put on the market. It collects information in a huge database to try to spot problems. But a handful of researchers tucked away in a university are using a completely different approach--and spotting problems years before the FDA could. Find out how these medical detectives do it.
